Need professional-grade analysis? Visit stockanalysis.com
$3.92B
N/A
N/A
196.00%
Shanghai Labway Clinical Laboratory Co Ltd (301060) trades on SHE in CNY. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at CNY9.74, down 2.11% from the previous close.
Over the past year, 301060 has traded between a low of CNY8.63 and a high of CNY13.68. The stock has gained 11.5% over this period. It is currently 28.8% below its 52-week high.
Shanghai Labway Clinical Laboratory Co Ltd has a market capitalization of $3.92B and a dividend yield of 196.00%.
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing; and professional technical support services. In addition, the company offers rental, business, and human resources services. Further, it operates Lanwei Academy that provides open courses and internal training. The company serves medical and scientific research institutes. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is headquartered in Shanghai, China.
Side-by-side comparison against top Healthcare peers.